Aviva PLC Cor Medix Inc. Transaction History
Aviva PLC
- $52.8 Billion
- Q3 2025
A detailed history of Aviva PLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Aviva PLC holds 38,030 shares of CRMD stock, worth $431,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,030Holding current value
$431,260% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRMD
# of Institutions
201Shares Held
36.2MCall Options Held
1.34MPut Options Held
1.26M-
Vanguard Group Inc Valley Forge, PA3.98MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.32MShares$37.7 Million0.74% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...